# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-23-126869
Filing Date
2023-04-28
Accepted
2023-04-28 16:04:15
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-04-28

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | d437710dars.pdf | ARS | 17542541
| Complete submission text file | 0001193125-23-126869.txt |  | 24164530

Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Filer) CIK: 0001822462 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-39634 | Film No.: 23865806
SIC: 2834 Pharmaceutical Preparations